Short Interest in Merck KGaA (OTCMKTS:MKKGY) Declines By 88.9%

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 900 shares, a decline of 88.9% from the February 28th total of 8,100 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 129,800 shares, the short-interest ratio is currently 0.0 days.

Merck KGaA Price Performance

Shares of MKKGY stock traded up $0.52 on Friday, reaching $27.75. The company’s stock had a trading volume of 157,554 shares, compared to its average volume of 127,004. The company has a market capitalization of $17.93 billion, a P/E ratio of 17.13, a PEG ratio of 2.05 and a beta of 0.98. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The stock’s 50 day simple moving average is $29.15 and its 200-day simple moving average is $31.05. Merck KGaA has a 12-month low of $27.19 and a 12-month high of $39.17.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings data on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.07. The firm had revenue of $5.78 billion for the quarter, compared to analysts’ expectations of $5.40 billion. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. As a group, equities analysts predict that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.